{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["2\u2019-O-methyltransferase", "COVID-19", "In silico screening", "Main protease", "Natural compounds", "Papain-like protease", "RNA-dependent RNA polymerase"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34308530", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "10"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "07", "Day": "25"}], "Language": ["eng"], "ELocationID": ["10.1007/s12539-021-00461-4"], "Journal": {"ISSN": "1867-1462", "JournalIssue": {"Volume": "14", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Mar"}}, "Title": "Interdisciplinary sciences, computational life sciences", "ISOAbbreviation": "Interdiscip Sci"}, "ArticleTitle": "Target-Based In Silico Screening for Phytoactive Compounds Targeting SARS-CoV-2.", "Pagination": {"StartPage": "64", "EndPage": "79", "MedlinePgn": "64-79"}, "Abstract": {"AbstractText": ["Coronavirus disease 2019 (COVID-19), resulting from infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause severe and fatal pneumonia along with other life-threatening complications. The COVID-19 pandemic has taken a heavy toll on the healthcare system globally and has hit the economy hard in all affected countries. As a result, there is an unmet medical need for both the prevention and treatment of COVID-19 infection. Several herbal remedies have claimed to show promising clinical results, but the mechanisms of action are not clear. We set out to identify the anti-viral natural products of these herbal remedies that presumably inhibit the life cycle of SARS-CoV-2. Particularly we chose four key SARS-CoV-2 viral enzymes as targets: Papain-like protease, Main protease, RNA dependent RNA polymerase, and 2'-O-ribose methyltransferase, which were subjected to an unbiased in silico screening against a small molecule library of 33,765 compounds originating from herbs and medicinal plants. The small molecules were then ranked based on their free energy of fitting into the \"druggable\" pockets on the surface of each target protein. We have analyzed the best \"fit\" molecules and annotated them according to their plant sources and pharmacokinetic properties. Here we present a list of potential anti-viral ingredients of herbal remedies targeting SARS-CoV-2 and explore the potential mechanisms of action of these compounds as a framework for further development of chemoprophylaxis agents against COVID-19."], "CopyrightInformation": "\u00a9 2021. International Association of Scientists in the Interdisciplinary Areas."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Computing Center, Beijing Academy of Science and Technology, 7 Fengxian Road, Beijing, 100094, China. yongzhao168@gmail.com."}], "LastName": "Zhao", "ForeName": "Yong", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Urology, Peking University Third Hospital, Beijing, 100191, China. tianyu@bjmu.edu.cn."}], "LastName": "Tian", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Beijing Computing Center, Beijing Academy of Science and Technology, 7 Fengxian Road, Beijing, 100094, China."}], "LastName": "Pan", "ForeName": "Chenling", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China."}], "LastName": "Liang", "ForeName": "Aihua", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON, Canada."}, {"Identifier": [], "Affiliation": "CIFAR Azrieli Global Scholars Program, Canadian Institute for Advanced Research, Toronto, ON, Canada."}], "LastName": "Zhang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": ["0000-0003-4083-7983"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Department of Biology, York University, Life Sciences Building 327B, 4700 Keele Street, Toronto, ON, M3J 1P3, Canada. yisheng@yorku.ca."}], "LastName": "Sheng", "ForeName": "Yi", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Germany", "MedlineTA": "Interdiscip Sci", "NlmUniqueID": "101515919", "ISSNLinking": "1867-1462"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}], "MeshHeadingList": [{"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Pandemics"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "All authors declare that there is no financial/personal interest or belief that could affect research objectivity and professional judgement concerning the validity of this research."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020;579:265\u2013269. doi: 10.1038/s41586-020-2008-3.", "ArticleIdList": ["10.1038/s41586-020-2008-3", "PMC7094943", "32015508"]}, {"Citation": "Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet. 2015;386:995\u20131007. doi: 10.1016/S0140-6736(15)60454-8.", "ArticleIdList": ["10.1016/S0140-6736(15)60454-8", "PMC4721578", "26049252"]}, {"Citation": "Chen Y, Liu Q, Guo D. Emerging coronaviruses: Genome structure, replication, and pathogenesis. J Med Virol. 2020;92:418\u2013423. doi: 10.1002/jmv.25681.", "ArticleIdList": ["10.1002/jmv.25681", "PMC7167049", "31967327"]}, {"Citation": "Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res. 2020;24:91\u201398. doi: 10.1016/j.jare.2020.03.005.", "ArticleIdList": ["10.1016/j.jare.2020.03.005", "PMC7113610", "32257431"]}, {"Citation": "Runfeng L, Yunlong H, Jicheng H, et al. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharmacol Res. 2020;156:104761. doi: 10.1016/j.phrs.2020.104761.", "ArticleIdList": ["10.1016/j.phrs.2020.104761", "PMC7102548", "32205232"]}, {"Citation": "Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020 doi: 10.1002/jmv.25783.", "ArticleIdList": ["10.1002/jmv.25783", "PMC7228368", "32198776"]}, {"Citation": "Yang Y, Islam MS, Wang J, Li Y, Chen X. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): a review and perspective. Int J Biol Sci. 2020;16:1708\u20131717. doi: 10.7150/ijbs.45538.", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Ang L, Lee HW, Choi JY, Zhang J, Soo LM. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines. Integr Med Res. 2020;9:100407. doi: 10.1016/j.imr.2020.100407.", "ArticleIdList": ["10.1016/j.imr.2020.100407", "PMC7104236", "32289016"]}, {"Citation": "Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20132046. doi: 10.1016/s0140-6736(03)13615-x.", "ArticleIdList": ["10.1016/s0140-6736(03)13615-x", "PMC7112442", "12814717"]}, {"Citation": "Fiore C, Eisenhut M, Krausse R, et al. Antiviral effects of Glycyrrhiza species. Phytotherapy research : PTR. 2008;22:141\u2013148. doi: 10.1002/ptr.2295.", "ArticleIdList": ["10.1002/ptr.2295", "PMC7167979", "17886224"]}, {"Citation": "Hoever G, Baltina L, Michaelis M, et al. Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. J Med Chem. 2005;48:1256\u20131259. doi: 10.1021/jm0493008.", "ArticleIdList": ["10.1021/jm0493008", "15715493"]}, {"Citation": "Chen CY. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico. PLoS ONE. 2011;6:e15939. doi: 10.1371/journal.pone.0015939.", "ArticleIdList": ["10.1371/journal.pone.0015939", "PMC3017089", "21253603"]}, {"Citation": "Irwin JJ, Shoichet BK. ZINC\u2013a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45:177\u2013182. doi: 10.1021/ci049714+.", "ArticleIdList": ["10.1021/ci049714+", "PMC1360656", "15667143"]}, {"Citation": "O'Boyle NM, Banck M, James CA, Morley C, Vandermeersch T, Hutchison GR. Open Babel: an open chemical toolbox. J Cheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33.", "ArticleIdList": ["10.1186/1758-2946-3-33", "PMC3198950", "21982300"]}, {"Citation": "Guo R, Zhang Y, Li X, Song X, Li D, Zhao Y. Discovery of ERBB3 inhibitors for non-small cell lung cancer (NSCLC) via virtual screening. J Mol Model. 2016;22:135. doi: 10.1007/s00894-016-3007-z.", "ArticleIdList": ["10.1007/s00894-016-3007-z", "27188722"]}, {"Citation": "Li X, Zhang Y, Chen H, Li H, Zhao Y. Insights into the molecular basis of the acute contact toxicity of diverse organic chemicals in the honey bee. J Chem Inf Model. 2017;57:2948\u20132957. doi: 10.1021/acs.jcim.7b00476.", "ArticleIdList": ["10.1021/acs.jcim.7b00476", "29161513"]}, {"Citation": "Weisel M, Proschak E, Schneider G. PocketPicker: analysis of ligand binding-sites with shape descriptors. Chem Cent J. 2007;1:7. doi: 10.1186/1752-153X-1-7.", "ArticleIdList": ["10.1186/1752-153X-1-7", "PMC1994066", "17880740"]}, {"Citation": "Park H, Lee J, Lee S. Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins. 2006;65:549\u2013554. doi: 10.1002/prot.21183.", "ArticleIdList": ["10.1002/prot.21183", "16988956"]}, {"Citation": "Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "Lill MA, Danielson ML. Computer-aided drug design platform using PyMOL. J Comput Aided Mol Des. 2011;25:13\u201319. doi: 10.1007/s10822-010-9395-8.", "ArticleIdList": ["10.1007/s10822-010-9395-8", "21053052"]}, {"Citation": "Abraham MJ, Gready JE (2011) Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J Comput Chem 32:2031\u20132040. 10.1002/jcc.21773.", "ArticleIdList": ["21469158"]}, {"Citation": "Sagui C, Darden TA. Molecular dynamics simulations of biomolecules: long-range electrostatic effects. Annu Rev Biophys Biomol Struct. 1999;28:155\u2013179. doi: 10.1146/annurev.biophys.28.1.155.", "ArticleIdList": ["10.1146/annurev.biophys.28.1.155", "10410799"]}, {"Citation": "Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Shah S, Chaple D, Arora S, Yende S, Mehta C, Nayak U. Prospecting for Cressa cretica to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2. J Biomol Struct Dyn 2021:1\u201310. 10.1080/07391102.2021.1872419.", "ArticleIdList": ["PMC7814567", "33446077"]}, {"Citation": "Bailey-Elkin BA, Knaap RC, Johnson GG, et al. Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 2014;289:34667\u201334682. doi: 10.1074/jbc.M114.609644.", "ArticleIdList": ["10.1074/jbc.M114.609644", "PMC4263872", "25320088"]}, {"Citation": "Ratia K, Pegan S, Takayama J, et al. A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proc Natl Acad Sci USA. 2008;105:16119\u201316124. doi: 10.1073/pnas.0805240105.", "ArticleIdList": ["10.1073/pnas.0805240105", "PMC2571001", "18852458"]}, {"Citation": "Baez-Santos YM, St John SE, Mesecar AD. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds. Antiviral Res. 2015;115:21\u201338. doi: 10.1016/j.antiviral.2014.12.015.", "ArticleIdList": ["10.1016/j.antiviral.2014.12.015", "PMC5896749", "25554382"]}, {"Citation": "Bekes M, van der Heden van Noort GJ, Ekkebus R, Ovaa H, Huang TT, Lima CD (2016) Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease. Mol Cell 62:572\u2013585. 10.1016/j.molcel.2016.04.016.", "ArticleIdList": ["PMC4875570", "27203180"]}, {"Citation": "Ghosh AK, Xi K, Johnson ME, Baker SC, Mesecar AD. Progress in Anti-SARS coronavirus chemistry, biology and chemotherapy. Annu Rep Med Chem. 2007;41:183\u2013196. doi: 10.1016/S0065-7743(06)41011-3.", "ArticleIdList": ["10.1016/S0065-7743(06)41011-3", "PMC2718771", "19649165"]}, {"Citation": "Baez-Santos YM, Barraza SJ, Wilson MW, et al. X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases. J Med Chem. 2014;57:2393\u20132412. doi: 10.1021/jm401712t.", "ArticleIdList": ["10.1021/jm401712t", "PMC3983375", "24568342"]}, {"Citation": "Baez-Santos YM, Mielech AM, Deng X, Baker S, Mesecar AD. Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus. J Virol. 2014;88:12511\u201312527. doi: 10.1128/JVI.01294-14.", "ArticleIdList": ["10.1128/JVI.01294-14", "PMC4248884", "25142582"]}, {"Citation": "Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. Targeting SARS-CoV-2 main protease: a computational drug repurposing study. Arch Med Res. 2021;52:38\u201347. doi: 10.1016/j.arcmed.2020.09.013.", "ArticleIdList": ["10.1016/j.arcmed.2020.09.013", "PMC7498210", "32962867"]}, {"Citation": "Chen S, Chen L, Tan J, et al. (2005) Severe acute respiratory syndrome coronavirus 3C-like proteinase N terminus is indispensable for proteolytic activity but not for enzyme dimerization. Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations. J Biol Chem 280:164\u2013173. 10.1074/jbc.M408211200.", "ArticleIdList": ["PMC7982548", "15507456"]}, {"Citation": "Hsu MF, Kuo CJ, Chang KT, et al. Mechanism of the maturation process of SARS-CoV 3CL protease. J Biol Chem. 2005;280:31257\u201331266. doi: 10.1074/jbc.M502577200.", "ArticleIdList": ["10.1074/jbc.M502577200", "PMC8062786", "15788388"]}, {"Citation": "Huang C, Wei P, Fan K, Liu Y, Lai L. 3C-like proteinase from SARS coronavirus catalyzes substrate hydrolysis by a general base mechanism. Biochemistry. 2004;43:4568\u20134574. doi: 10.1021/bi036022q.", "ArticleIdList": ["10.1021/bi036022q", "15078103"]}, {"Citation": "Shi J, Wei Z, Song J. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J Biol Chem. 2004;279:24765\u201324773. doi: 10.1074/jbc.M311744200.", "ArticleIdList": ["10.1074/jbc.M311744200", "PMC7982319", "15037623"]}, {"Citation": "Yang H, Yang M, Ding Y, et al. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc Natl Acad Sci U S A. 2003;100:13190\u201313195. doi: 10.1073/pnas.1835675100.", "ArticleIdList": ["10.1073/pnas.1835675100", "PMC263746", "14585926"]}, {"Citation": "Jin Z, Du X, Xu Y, et al. Structure of M(pro) from COVID-19 virus and discovery of its inhibitors. Nature. 2020 doi: 10.1038/s41586-020-2223-y.", "ArticleIdList": ["10.1038/s41586-020-2223-y", "32272481"]}, {"Citation": "Anand K, Ziebuhr J, Wadhwani P, Mesters JR, Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300:1763\u20131767. doi: 10.1126/science.1085658.", "ArticleIdList": ["10.1126/science.1085658", "12746549"]}, {"Citation": "Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005;3:e324. doi: 10.1371/journal.pbio.0030324.", "ArticleIdList": ["10.1371/journal.pbio.0030324", "PMC1197287", "16128623"]}, {"Citation": "Ho BL, Cheng SC, Shi L, Wang TY, Ho KI, Chou CY. Critical assessment of the important residues involved in the dimerization and catalysis of MERS coronavirus main protease. PLoS ONE. 2015;10:e0144865. doi: 10.1371/journal.pone.0144865.", "ArticleIdList": ["10.1371/journal.pone.0144865", "PMC4682845", "26658006"]}, {"Citation": "Ryu YB, Jeong HJ, Kim JH, et al. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition. Bioorg Med Chem. 2010;18:7940\u20137947. doi: 10.1016/j.bmc.2010.09.035.", "ArticleIdList": ["10.1016/j.bmc.2010.09.035", "PMC7126309", "20934345"]}, {"Citation": "Schwarz S, Sauter D, Wang K, et al. Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus. Planta Med. 2014;80:177\u2013182. doi: 10.1055/s-0033-1360277.", "ArticleIdList": ["10.1055/s-0033-1360277", "PMC7171712", "24458263"]}, {"Citation": "Kirchdoerfer RN, Ward AB. Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors. Nat Commun. 2019;10:2342. doi: 10.1038/s41467-019-10280-3.", "ArticleIdList": ["10.1038/s41467-019-10280-3", "PMC6538669", "31138817"]}, {"Citation": "Gao Y, Yan L, Huang Y, et al. Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science. 2020 doi: 10.1126/science.abb7498.", "ArticleIdList": ["10.1126/science.abb7498", "PMC7164392", "32277040"]}, {"Citation": "Chen Y, Su C, Ke M, et al. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2'-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog. 2011;7:e1002294. doi: 10.1371/journal.ppat.1002294.", "ArticleIdList": ["10.1371/journal.ppat.1002294", "PMC3192843", "22022266"]}, {"Citation": "Menachery VD, Yount BL, Jr, Josset L, et al. Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity. J Virol. 2014;88:4251\u20134264. doi: 10.1128/JVI.03571-13.", "ArticleIdList": ["10.1128/JVI.03571-13", "PMC3993736", "24478444"]}, {"Citation": "Decroly E, Debarnot C, Ferron F, et al. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog. 2011;7:e1002059. doi: 10.1371/journal.ppat.1002059.", "ArticleIdList": ["10.1371/journal.ppat.1002059", "PMC3102710", "21637813"]}, {"Citation": "Abdullah, Faisal S, Aman K, Rahman AU (2020) Innate immune-mediated antiviral response to SARS-CoV-2 and convalescent sera a potential prophylactic and therapeutic agent to tackle COVID-19. Antib Ther 3:212\u2013220. 10.1093/abt/tbaa019.", "ArticleIdList": ["PMC7454257", "33912794"]}, {"Citation": "Jan H, Faisal S, Khan A, et al. COVID-19: review of epidemiology and potential treatments against 2019 novel coronavirus. Discoveries (Craiova) 2020;8:e108. doi: 10.15190/d.2020.5.", "ArticleIdList": ["10.15190/d.2020.5", "PMC7199242", "32377559"]}, {"Citation": "Holmes EC, Rambaut A. Viral evolution and the emergence of SARS coronavirus. Philos Trans R Soc Lond B Biol Sci. 2004;359:1059\u20131065. doi: 10.1098/rstb.2004.1478.", "ArticleIdList": ["10.1098/rstb.2004.1478", "PMC1693395", "15306390"]}, {"Citation": "Giovanetti M, Angeletti S, Benvenuto D, Ciccozzi M. A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview. J Med Virol. 2020;92:1634\u20131636. doi: 10.1002/jmv.25773.", "ArticleIdList": ["10.1002/jmv.25773", "PMC7228217", "32190908"]}, {"Citation": "Baby K, Maity S, Mehta CH, Suresh A, Nayak UY, Nayak Y. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: an in silico drug repurposing study. Eur J Pharmacol. 2021;896:173922. doi: 10.1016/j.ejphar.2021.173922.", "ArticleIdList": ["10.1016/j.ejphar.2021.173922", "PMC8060391", "33539819"]}, {"Citation": "Ma SC, But PP, Ooi VE, et al. Antiviral amentoflavone from Selaginella sinensis. Biol Pharm Bull. 2001;24:311\u2013312. doi: 10.1248/bpb.24.311.", "ArticleIdList": ["10.1248/bpb.24.311", "11256492"]}, {"Citation": "Pan X, Tan N, Zeng G, Zhang Y, Jia R. Amentoflavone and its derivatives as novel natural inhibitors of human Cathepsin B. Bioorg Med Chem. 2005;13:5819\u20135825. doi: 10.1016/j.bmc.2005.05.071.", "ArticleIdList": ["10.1016/j.bmc.2005.05.071", "16084098"]}, {"Citation": "Wu YX, Kim YJ, Kwon TH, Tan CP, Son KH, Kim T. Anti-inflammatory effects of mulberry (Morus alba L.) root bark and its active compounds. Nat Prod Res 2018:1\u20134. 10.1080/14786419.2018.1527832.", "ArticleIdList": ["30470128"]}, {"Citation": "Adhikari B, Marasini BP, Rayamajhee B, et al. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother Res. 2021;35:1298\u20131312. doi: 10.1002/ptr.6893.", "ArticleIdList": ["10.1002/ptr.6893", "PMC7675695", "33037698"]}, {"Citation": "Ang L, Lee HW, Kim A, Lee JA, Zhang J, Lee MS. Herbal medicine for treatment of children diagnosed with COVID-19: a review of guidelines. Complement Ther Clin Pract. 2020;39:101174. doi: 10.1016/j.ctcp.2020.101174.", "ArticleIdList": ["10.1016/j.ctcp.2020.101174", "PMC7152923", "32379639"]}, {"Citation": "Luo H, Gao Y, Zou J, et al. Reflections on treatment of COVID-19 with traditional Chinese medicine. Chin Med. 2020;15:94. doi: 10.1186/s13020-020-00375-1.", "ArticleIdList": ["10.1186/s13020-020-00375-1", "PMC7468089", "32905189"]}, {"Citation": "Ding Y, Zeng L, Li R, et al. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Complement Altern Med. 2017;17:130. doi: 10.1186/s12906-017-1585-7.", "ArticleIdList": ["10.1186/s12906-017-1585-7", "PMC5324200", "28235408"]}, {"Citation": "Zhou W, Zhang XY. Research progress of Chinese herbal medicine Radix isatidis (banlangen) Am J Chin Med. 2013;41:743\u2013764. doi: 10.1142/S0192415X1350050X.", "ArticleIdList": ["10.1142/S0192415X1350050X", "23895149"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "7"}, {"Year": "2021", "Month": "7", "Day": "4"}, {"Year": "2021", "Month": "7", "Day": "1"}, {"Year": "2021", "Month": "7", "Day": "27", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "26", "Hour": "6", "Minute": "57"}, {"Year": "2021", "Month": "7", "Day": "25"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34308530", "PMC8310681", "10.1007/s12539-021-00461-4", "10.1007/s12539-021-00461-4"]}}], "PubmedBookArticle": []}